Cargando…

COVID-19 thromboembolism is reduced in ambulatory, but not hospitalized patients, following COVID-19 vaccination

Detalles Bibliográficos
Autores principales:	Stevens, Hannah, Ruiz-Carmona, Sergio, Peter, Karlheinz, McFadyen, James D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483365/ https://www.ncbi.nlm.nih.gov/pubmed/36700407 http://dx.doi.org/10.3324/haematol.2022.282262

Ejemplares similares

The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications
por: McFadyen, James D., et al.
Publicado: (2020)

Inherited Thrombophilias Are Associated with an Increased Risk of COVID-19 Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study
por: Stevens, Hannah P, et al.
Publicado: (2021)

Predicting the Risk of Recurrent Venous Thromboembolism: Current Challenges and Future Opportunities
por: Stevens, Hannah, et al.
Publicado: (2020)

Acute venous thromboembolism after COVID-19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Thromboembolic events following mRNA vaccines for COVID 19: a case series
por: Serrao, Alessandra, et al.
Publicado: (2022)

Trends in ambulatory cardiology consultations for suspected myocarditis after COVID-19 vaccination
por: Eggebrecht, Holger, et al.
Publicado: (2021)

Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors
por: Spyropoulos, Alex C., et al.
Publicado: (2021)

Regarding the Article: A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19
por: LEÓN-ROSALES, SAMUEL PONCE DE, et al.
Publicado: (2022)

Response to: Regarding the Article: A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19
por: BONILLA, CÉSAR RAÚL GONZALEZ
Publicado: (2022)

Thromboembolic and Bleeding Complications in Transcatheter Aortic Valve Implantation: Insights on Mechanisms, Prophylaxis and Therapy
por: Ranasinghe, Mark P., et al.
Publicado: (2019)

Favipiravir and the Need for Early Ambulatory Treatment of COVID-19
por: Korman, Tony M.
Publicado: (2021)

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

Early thromboembolic events in hospitalized COVID-19 patients
por: Rosen, Raphael J.
Publicado: (2020)

COVID-19 thromboembolic complications: Deepening immunoinflammatory features
por: Roncati, Luca, et al.
Publicado: (2021)

Bell’s palsy following COVID-19 vaccination
por: Colella, Giuseppe, et al.
Publicado: (2021)

Persistent pruritus following COVID-19 vaccination
por: Doyle, C., et al.
Publicado: (2022)

Immune Thrombocytopenia Following COVID-19 Vaccination
por: Isaac, Sangeetha, et al.
Publicado: (2022)

Predictors of thromboembolic events in COVID-19 ambulatory patients
por: Hammami, R., et al.
Publicado: (2022)

C-reactive protein, immunothrombosis and venous thromboembolism
por: Dix, Caroline, et al.
Publicado: (2022)

When To Retest: an Examination of Repeat COVID-19 PCR Patterns in an Ambulatory Population
por: Greene, Dina N., et al.
Publicado: (2020)

Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients
por: Mentzer, Alexander J, et al.
Publicado: (2022)

Bullous pemphigoid and COVID-19 vaccine()
por: Pérez-López, Israel, et al.
Publicado: (2021)

Abnormal Thyroid Function Following COVID-19 Vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Acute Myocardial Injury Following COVID-19 Vaccination
por: sookaromdee, Pathum, et al.
Publicado: (2021)

Cerebral Venous Thrombosis following COVID-19 Vaccination
por: Kow, Chia Siang, et al.
Publicado: (2021)

Parsonage–Turner Syndrome Following COVID-19 Vaccine
por: Sharma, Rajaram, et al.
Publicado: (2022)

Systemic Lupus Erythematosus Following COVID-19 Vaccination
por: Salleh, Anna Farazilah Mohd, et al.
Publicado: (2022)

The thromboembolic risk in covid-19 women under hormonal treatment group
por: Ramírez, Isabel, et al.
Publicado: (2020)

COVID-19-Associated Thromboembolic Events Causing Acute Mesenteric Ischaemia
por: Fan, Bingwen Eugene
Publicado: (2020)

Corticosteroid therapy in COVID-19 patients: Don’t forget venous thromboembolism
por: Roncon, Loris, et al.
Publicado: (2021)

COVID‐19, Virchow's triad and thromboembolic risk in obese pregnant women
por: Carbillon, Lionel, et al.
Publicado: (2021)

Submassive Pulmonary Embolism: Current Perspectives and Future Directions
por: Nguyen, Phillip C., et al.
Publicado: (2021)

Thromboembolic risks in patients with COVID-19: major concern to consider in our management
por: Temgoua, Mazou Ngou, et al.
Publicado: (2020)

Ongoing trials on COVID-19 treatments: please, don’t forget Venous Thromboembolism!
por: Zuin, Marco, et al.
Publicado: (2021)

Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19
por: Zhu, Xiangyu, et al.
Publicado: (2021)

Paraparesis due to aortic thromboembolism as a rare complication of COVID-19 infection
por: Motahharynia, Ali, et al.
Publicado: (2021)

Painless thyroiditis following mRNA vaccination for COVID-19
por: Nakaizumi, Nobuhiko, et al.
Publicado: (2022)

Immune thrombocytopenia following vaccination during the COVID-19 pandemic
por: Choi, Philip Young-Ill, et al.
Publicado: (2021)

Immune Thrombocytopenic Purpura Cases Following COVID-19 Vaccination
por: Condorelli, Annalisa, et al.
Publicado: (2021)

Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7i9gg6dc4ucmtqfdmif20suv9c